Evaluation of safety and efficacy of elective PCI in patients with cardiac insufficiency
Affiliations: Ultrasound Room, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830063, P.R. China, Department of Cardiology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830063, P.R. China, Department of Anatomy, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China
- Published online on: December 27, 2016 https://doi.org/10.3892/etm.2016.4005
- Pages: 609-613
Copyright: © Jing et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...
This article is mentioned in:
We analyzed the safety and the efficacy of the treatment with elective percutaneous coronary intervention (PCI) in patients with coronary heart disease complicated with cardiac insufficiency. We enrolled 217 patients diagnosed with chronic ischemic heart disease complicated with cardiac failure. According to the type of treatment they received, patients were divided into 3 groups: i) The conservative treatment group with 60 patients (they received standard medication); ii) the early PCI group with 82 cases (their condition was stabilized, surgical risk was assessed and PCI was taken as early as possible); and iii) the advanced PCI group with 75 cases (ischemic myocardium was corrected and then elective PCI was applied and for aggravated myocardial ischemia cases, PCI was applied after assessing the risk of surgery). Follow‑up visits were set for approximately 3 years and clinical outcomes were compared. Our results showed that the survival time in the early PCI group was significantly prolonged and the survival rate was considerably increased during 3 years. Left ventricular ejection fraction in the early PCI group markedly increased and left ventricular end‑diastolic diameter and pro‑BNP level decreased significantly. The occurrence rates of perioperative complications in the early PCI group and major adverse cardiac events (MACE) during the follow‑up period were significantly reduced. Quality of life scores in the early PCI group markedly improved. We concluded that in patients with coronary heart disease complicated with cardiac insufficiency, early PCI treatment was safe and effective.